– Fermion y Simcere firman un acuerdo exclusivo de licencia y colaboración para el primer agonista SSTR4 de China dirigido al dolor GUANGZHOU, China, 20 de enero de 2025 /PRNewswire/ — Guangzhou Fermion Technology Co., Ltd. y Simcere Pharmaceutical Group Limited (HKEX: 2096) han…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.